Report Highlights Growing Shortage of Breast Imaging Radiologists
A new data-driven report from Medicus Healthcare Solutions details a persistent shortage of breast imaging radiologists. This specialized staffing challenge puts pressure on health systems and outpatient centers to maintain timely access to mammography and related diagnostic services.
- The U.S. has approximately 7,500 breast imaging radiologists, which equates to about four for every 100,000 women aged 40 and older. This scarcity is intensified by the 2024 updated screening guidelines from the US Preventive Services Task Force, which expanded the mammography market by about 20 million newly eligible women by lowering the recommended screening age to 40. - A survey by the Society of Breast Imaging found that 79% of radiology practices report being short-staffed for breast imagers, a situation worsened by high burnout rates. Studies have shown that over 78% of breast radiologists experience burnout in at least one dimension, with factors like high workload and prolonged concentration contributing. - The challenge of filling the talent pipeline is evident in fellowship matching data, where applicant-to-position ratios for breast imaging have remained below 1.0 from 2021 to 2025. In 2025, there were 204 fellowship positions available, but only 162 were filled. - The trend of shifting imaging services to outpatient settings is growing, with these centers now handling about 40% of all imaging volumes. This move is driven by the lower costs and greater convenience offered by freestanding and ambulatory clinics compared to traditional hospital settings. - Health systems are actively acquiring or partnering with freestanding imaging centers to create integrated networks. These joint ventures allow hospitals to expand their outpatient footprint, standardize care, and improve operational efficiency. - Artificial intelligence is emerging as a critical tool to mitigate the radiologist shortage by improving workflow efficiency and diagnostic accuracy. AI applications, some of which are FDA-approved, can assist with triage, lesion detection and classification, and assessing breast density. - In a significant advancement, the FDA has recently authorized the first AI tools capable of predicting a woman's five-year risk of developing breast cancer from a routine mammogram alone. This technology, developed by companies like Therapixel and Clairity, analyzes tissue patterns that are often imperceptible to the human eye to provide a risk score.
